Skip to main content
Equibles

VANGUARD CAPITAL MANAGEMENT LLC

Position in LUNG — Pulmonx Corp

CIK 2100119 MALVERN, PA
Back to LUNG Full portfolio

Position in LUNG

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,119,284
+$11,084 QoQ
Shares Held
1,630,219
-0.2% QoQ
Ownership
3.80%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 108 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in LUNG Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

VANGUARD CAPITAL MANAGEMENT LLC holds $42,477,438,602 across 118 Medical Devices names. LUNG ranks #84 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 113,750,994 $10,321,765,195
2 SYK
Stryker Corp
 22,536,843 $7,095,499,650
3 MDT
Medtronic plc
 83,816,735 $6,556,983,179
4 BSX
Boston Scientific Corp
 97,087,553 $4,143,696,762
5 EW
Edwards Lifesciences Corp
 37,615,952 $3,402,739,017
6 GEHC
GE HealthCare Technologies Inc.
 29,724,359 $1,902,656,219
7 DXCM
Dexcom Inc
 25,209,752 $1,697,876,797
8 STE
STERIS plc
 6,406,906 $1,349,102,196

All Filings in LUNG

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,119,284 1,630,219
2026-03-31 $2,108,200 1,634,264